Thurston Springer Miller Herd & Titak’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.48K	Hold	22	–	–	﹤0.01%	1037
2026 Q1	$2.81K	Hold	22	–	–	﹤0.01%	1137
2025 Q4	$2.68K	Buy	+22	New	+$2.52K	﹤0.01%	1183
2025 Q3	–	Sell	-342	Closed	-$28.4K	–	1375
2025 Q2	$28.4K	Buy	342 +115	+51%	+$9.17K	﹤0.01%	831
2025 Q1	$18.4K	Sell	227 -75	-25%	-$6.7K	﹤0.01%	909
2024 Q4	$27.2K	Sell	302 -13	-4%	-$1.26K	0.01%	657
2024 Q3	$31.1K	Buy	315 +56	+22%	+$5.5K	0.01%	687
2024 Q2	$24K	Buy	+259	New	+$23.2K	0.01%	761

Other funds holding XBI

PSP Research Newtown Square, Pennsylvania $188M AUM

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

MFS

Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

WTC

WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's XBI Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 22 shares worth $3.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Thurston Springer Miller Herd & Titak first reported a position in XBI in Q2 2024 and has held it in 8 quarters since. The position peaked at $31.1K in Q3 2024. 326 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Thurston Springer Miller Herd & Titak held 22 shares of State Street SPDR S&P Biotech ETF worth $3.48K as of Q2 2026.
Thurston Springer Miller Herd & Titak left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #1037 holding.
Thurston Springer Miller Herd & Titak first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and has held it in 8 quarters since.
Thurston Springer Miller Herd & Titak's State Street SPDR S&P Biotech ETF position peaked at $31.1K in Q3 2024.
326 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.